Open Access

The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy

  • Authors:
    • Chen Wang
    • Jingwei Chi
    • Kui Che
    • Xiaolong Ma
    • Mingyue Qiu
    • Zhongchao Wang
    • Yangang Wang
  • View Affiliations

  • Published online on: March 13, 2019     https://doi.org/10.3892/etm.2019.7383
  • Pages: 3555-3563
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetic neuropathy (DN) is one of the most common diabetic complications that results in an increase in patient discomfort and pain. The present study demonstrated that mesenchymal stem cells (MSCs) or resveratrol (RSV) may improve diabetic hyperglycemia and neuropathy. The aim of the present study was to investigate the combined effect of MSCs and RSV on DN. A total of 100 non‑obese diabetic mice were divided into the following six groups: Normal control, MSCs, RSV, MSCs + RSV, insulin and diabetic control groups. Following homologous therapy, the levels of blood glucose and C‑peptide, islets, nuclear factor (NF)‑κB, nerve growth factor (NGF) and myelin basic protein (MBP), and the sciatic nerve structure in each group were examined and evaluated. Following the administration of therapy, the levels of blood glucose and C‑peptide in mice in the MSCs + RSV group were significantly improved when compared with the other diabetic groups, and the dosage of insulin therapy required was the lowest among the six experimental groups (P<0.05). The levels of NGF, MBP and NF‑κB in the MSCs + RSV group were significantly improved compared with the MSCs and RSV groups (P<0.05). Furthermore, the diameter of the axon, number of myelinated nerve fibers and the depth of the myelin sheath in the MSCs + RSV group were greatest among the five examined groups (excluding the control). The combination of RSV and MSCs could relieve hyperglycemia and improve DN. This indicated that the combination of RSV and MSCs may be a novel therapeutic method for the treatment of DN.
View Figures
View References

Related Articles

Journal Cover

May-2019
Volume 17 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang C, Chi J, Che K, Ma X, Qiu M, Wang Z and Wang Y: The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy. Exp Ther Med 17: 3555-3563, 2019.
APA
Wang, C., Chi, J., Che, K., Ma, X., Qiu, M., Wang, Z., & Wang, Y. (2019). The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy. Experimental and Therapeutic Medicine, 17, 3555-3563. https://doi.org/10.3892/etm.2019.7383
MLA
Wang, C., Chi, J., Che, K., Ma, X., Qiu, M., Wang, Z., Wang, Y."The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy". Experimental and Therapeutic Medicine 17.5 (2019): 3555-3563.
Chicago
Wang, C., Chi, J., Che, K., Ma, X., Qiu, M., Wang, Z., Wang, Y."The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy". Experimental and Therapeutic Medicine 17, no. 5 (2019): 3555-3563. https://doi.org/10.3892/etm.2019.7383